Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Arrowhead Pharmaceuticals (ARWR) over the last 13 years, with Q4 2025 value amounting to $9.7 million.

  • Arrowhead Pharmaceuticals' Interest & Investment Income rose 2759.8% to $9.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $39.4 million, marking a year-over-year increase of 4316.13%. This contributed to the annual value of $37.3 million for FY2025, which is 6417.25% up from last year.
  • Arrowhead Pharmaceuticals' Interest & Investment Income amounted to $9.7 million in Q4 2025, which was up 2759.8% from $9.1 million recorded in Q3 2025.
  • In the past 5 years, Arrowhead Pharmaceuticals' Interest & Investment Income ranged from a high of $11.0 million in Q2 2025 and a low of $1.1 million during Q1 2022
  • Over the past 5 years, Arrowhead Pharmaceuticals' median Interest & Investment Income value was $4.0 million (recorded in 2023), while the average stood at $4.7 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first crashed by 4944.96% in 2021, then surged by 33263.76% in 2023.
  • Quarter analysis of 5 years shows Arrowhead Pharmaceuticals' Interest & Investment Income stood at $1.2 million in 2021, then surged by 132.01% to $2.7 million in 2022, then rose by 4.47% to $2.8 million in 2023, then skyrocketed by 171.31% to $7.6 million in 2024, then grew by 27.6% to $9.7 million in 2025.
  • Its Interest & Investment Income was $9.7 million in Q4 2025, compared to $9.1 million in Q3 2025 and $11.0 million in Q2 2025.